Search Results - Meghna Jani

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
    Drug safety and immunogenicity of tumour necrosis factor inhibitors: the story so far

    Drug safety and immunogenicity of tumour necrosis factor inhibitors: the story so far by Meghna Jani, William G Dixon, Hector Chinoy

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Prediction of infection risk in rheumatoid arthritis patients treated with biologics: are we any closer to risk stratification?

    Prediction of infection risk in rheumatoid arthritis patients treated with biologics: are we any closer to risk stratification? by Meghna Jani, Anne Barton, Kimme L Hyrich

    Published 2019
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    The Genetics of Psoriasis and Psoriatic Arthritis

    The Genetics of Psoriasis and Psoriatic Arthritis by Darren D. O’Rielly, Meghna Jani, Proton Rahman, James T. Elder

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Glucocorticoid use is associated with an increased risk of hypertension

    Glucocorticoid use is associated with an increased risk of hypertension by Ruth Costello, Belay Birlie Yimer, P Roads, Meghna Jani, William G Dixon

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Time trends and prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain: A retrospective cohort study

    Time trends and prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain: A retrospective cohort study by Meghna Jani, Belay Birlie Yimer, Thérèse Sheppard, Mark Lunt, William G Dixon

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases

    The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases by Meghna Jani, Anne Barton, Richard B. Warren, C.E.M. Griffiths, Hector Chinoy

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Frequent discussion of insomnia and weight gain with glucocorticoid therapy: an analysis of Twitter posts

    Frequent discussion of insomnia and weight gain with glucocorticoid therapy: an analysis of Twitter posts by Rikesh Patel, Maksim Belousov, Meghna Jani, Nabarun Dasgupta, Carly Winokur, Goran Nenadić, William G Dixon

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Assessing Immunogenicity of Biologic Drugs in Inflammatory Joint Diseases: Progress Towards Personalized Medicine

    Assessing Immunogenicity of Biologic Drugs in Inflammatory Joint Diseases: Progress Towards Personalized Medicine by Johanna Elin Gehin, Guro Løvik Goll, Marthe Kirkesæther Brun, Meghna Jani, Nils Bolstad, Silje Watterdal Syversen

    Published 2022
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    Comparative risk of severe constipation in patients treated with opioids for non-cancer pain: a retrospective cohort study in Northwest England

    Comparative risk of severe constipation in patients treated with opioids for non-cancer pain: a retrospective cohort study in Northwest England by Belay Birlie Yimer, Mehreen Soomro, John McBeth, Carlos Raul Ramirez Medina, Mark Lunt, William G Dixon, Meghna Jani

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis: results from the BRAGGSS cohort

    High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis: results from the BRAGGSS... by Meghna Jani, John D. Isaacs, Ann W. Morgan, Anthony G. Wilson, Darren Plant, Kimme L Hyrich, Hector Chinoy, Anne Barton

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Deficient transcription of XIST from tiny ring X chromosomes in females with severe phenotypes.

    Deficient transcription of XIST from tiny ring X chromosomes in females with severe phenotypes. by Barbara R. Migeon, Shengyuan Luo, Beth A. Stasiowski, Meghna Jani, Joyce Axelman, Daniel L. Van Dyke, Lester Weiss, P. A. Jacobs, Teresa L. Yang‐Feng, John E. Wiley

    Published 1993
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Clinical Utility of Random Anti–Tumor Necrosis Factor Drug–Level Testing and Measurement of Antidrug Antibodies on the Long‐Term Treatment Response in Rheumatoid Arthritis

    Clinical Utility of Random Anti–Tumor Necrosis Factor Drug–Level Testing and Measurement of Antidrug Antibodies on the Long‐Term Treatment Response in Rheumatoid Arthritis by Meghna Jani, Hector Chinoy, Richard B. Warren, C.E.M. Griffiths, Darren Plant, Bo Fu, Ann W. Morgan, Anthony G. Wilson, John D. Isaacs, Kimme L Hyrich, Anne Barton

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases

    2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases by Annette de Thurah, Philipp Bösch, Andréa Marques, Yvette Meißner, Chetan Mukhtyar, Johannes Knitza, Aurélie Najm, Nina Østerås, Tim Pelle, Line Raunsbæk Knudsen, Hana Šmucrová, Françis Berenbaum, Meghna Jani, Rinie Geenen, Martin Krusche, Polina Pchelnikova, Savia de Souza, Sara Badreh, Dieter Wiek, Silvia Piantoni, James M. Gwinnutt, Christina Duftner, Helena Canhão, Luca Quartuccio, Nikolay Stoilov, Yeliz Prior, J. W. J. Bijlsma, Alen Zabotti, Tanja Stamm, Christian Dejaco

    Published 2022
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases

    EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases by C. Krieckaert, Astrid van Tubergen, Johanna Elin Gehin, Borja Hernández‐Breijo, Guillaume Le Mélédo, Alejandro Balsa, Peter Böhm, Saša Čučnik, Ori Elkayam, Guro Løvik Goll, Femke Hooijberg, Meghna Jani, Patrick Kiely, Neil E. McCarthy, Denis Mulleman, Victoria Navarro‐Compán, Katherine Payne, Martin E Perry, Chamaida Plasencia‐Rodríguez, Simon Stones, Silje Watterdal Syversen, Annick de Vries, Katherine M Ward, Gertjan Wolbink, John D. Isaacs

    Published 2022
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  15. 15
    EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update by Josef S Smolen, Robert Landewé, Johannes Bijlsma, Gerd Burmester, Katerina Chatzidionysiou, Maxime Dougados, J. Nam, Sofía Ramiro, Marieke Voshaar, Ronald van Vollenhoven, Daniel Aletaha, Martin Aringer, Maarten Boers, Christopher D. Buckley, Frank Buttgereit, Vivian P. Bykerk, Myrna Cardiel, Bernard Combe, Maurizio Cutolo, Yvonne van Eijk‐Hustings, Paul Emery, Axel Finckh, Cem Gabay, Juan J. Gómez‐Reino, Laure Gossec, J.-E. Gottenberg, Johanna M W Hazes, T. Huizinga, Meghna Jani, Д. Е. Каратеев, Marios Kouloumas, Tore Kvien, Zhanguo Li, Xavier Mariette, Iain B. McInnes, Eduardo Mysler, Peter Nash, Karel Pavelká, Gyula Poór, Christophe Richez, Piet L. C. M. van Riel, Andrea Rubbert‐Roth, Kenneth G. Saag, José António Pereira da Silva, Tanja Stamm, Tsutomu Takeuchi, René Westhovens, Maarten de Wit, Désirée van der Heijde

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:

Search Tools: